miR-话题@MedSci

#miR#

540篇内容 | 2677人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1930862, encodeId=52d91930862c4, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=ARD：独特的循环miRNA谱突出了Behçet综合征中的血栓炎症, objectType=article, longId=301587, objectId=39d130158e4b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39d130158e4b, replyNumber=0, likeNumber=100, createdTime=2022-04-04, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39d130158e4b, moduleTitle=ARD：独特的循环miRNA谱突出了Behçet综合征中的血栓炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39d130158e4b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930838, encodeId=21b71930838eb, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Nat Commun：miRNA评分系统预测结直肠癌发病风险, objectType=article, longId=217994, objectId=de8a21e99420, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de8a21e99420, replyNumber=0, likeNumber=68, createdTime=2022-02-04, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de8a21e99420, moduleTitle=Nat Commun：miRNA评分系统预测结直肠癌发病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de8a21e99420)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930832, encodeId=70ca193083273, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Ann Oncol: MIRV对比研究者选择的化疗在铂耐药上皮性卵巢癌(EOC)患者中的疗效和安全性: III期研究FORWARD I的初次分析结果, objectType=article, longId=213341, objectId=9b0321334101, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b0321334101, replyNumber=0, likeNumber=91, createdTime=2021-09-11, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b0321334101, moduleTitle=Ann Oncol: MIRV对比研究者选择的化疗在铂耐药上皮性卵巢癌(EOC)患者中的疗效和安全性: III期研究FORWARD I的初次分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b0321334101)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930842, encodeId=0f1f1930842f3, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=美国FDA批准 Cyltezo（阿达木单抗-adbm）作为第一个可与Humira互换的生物仿制药, objectType=article, longId=218852, objectId=2c2e218852d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c2e218852d4, replyNumber=0, likeNumber=68, createdTime=2021-12-03, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c2e218852d4, moduleTitle=美国FDA批准 Cyltezo（阿达木单抗-adbm）作为第一个可与Humira互换的生物仿制药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c2e218852d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930854, encodeId=271b193085487, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Nat Commun：miRNA评分系统预测结直肠癌发病风险, objectType=article, longId=291937, objectId=7ac729193ee9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ac729193ee9, replyNumber=0, likeNumber=67, createdTime=2022-08-11, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ac729193ee9, moduleTitle=Nat Commun：miRNA评分系统预测结直肠癌发病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ac729193ee9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930844, encodeId=c644193084444, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=JEV:脂肪组织来源的干细胞细胞外囊泡通过骨保护素和miR-21-5p缓解骨质疏松症, objectType=article, longId=219108, objectId=d190219108b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d190219108b6, replyNumber=0, likeNumber=89, createdTime=2022-06-01, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d190219108b6, moduleTitle=JEV:脂肪组织来源的干细胞细胞外囊泡通过骨保护素和miR-21-5p缓解骨质疏松症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d190219108b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930843, encodeId=a8fa1930843cd, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=辉瑞和BioNTech的COVID-19疫苗Comirnaty对青少年具有高度保护作用, objectType=article, longId=218969, objectId=c1c72189695d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1c72189695d, replyNumber=0, likeNumber=79, createdTime=2022-06-14, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1c72189695d, moduleTitle=辉瑞和BioNTech的COVID-19疫苗Comirnaty对青少年具有高度保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1c72189695d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930864, encodeId=a44a193086444, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=复必泰（Comirnaty）加强针疫苗激发儿童对Omicron的免疫反应, objectType=article, longId=724340, objectId=56f7e24340a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56f7e24340a5, replyNumber=0, likeNumber=74, createdTime=2022-11-09, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56f7e24340a5, moduleTitle=复必泰（Comirnaty）加强针疫苗激发儿童对Omicron的免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56f7e24340a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930860, encodeId=73fb193086018, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Alvotech就美国专利和商业秘密纠纷与AbbVie达成和解，Alvotech的拟议Humira®高浓度生物仿制药(AVT02)可在美国销售, objectType=article, longId=300761, objectId=3b82300e6134, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b82300e6134, replyNumber=0, likeNumber=80, createdTime=2022-07-30, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b82300e6134, moduleTitle=Alvotech就美国专利和商业秘密纠纷与AbbVie达成和解，Alvotech的拟议Humira®高浓度生物仿制药(AVT02)可在美国销售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b82300e6134)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930833, encodeId=df58193083396, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=撤稿！中国学者连续被撤稿129篇文章，基本都是动物和细胞实验层面，尤其是miRNA和lncRNA仍然是重灾区, objectType=article, longId=214103, objectId=4b9721410380, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b9721410380, replyNumber=0, likeNumber=70, createdTime=2021-08-26, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b9721410380, moduleTitle=撤稿！中国学者连续被撤稿129篇文章，基本都是动物和细胞实验层面，尤其是miRNA和lncRNA仍然是重灾区, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b9721410380)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930848, encodeId=4c62193084852, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1, objectType=article, longId=220880, objectId=1f00220880cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f00220880cb, replyNumber=0, likeNumber=61, createdTime=2022-10-11, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f00220880cb, moduleTitle=miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f00220880cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930856, encodeId=f1d81930856f7, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=ARD：抗纤维化因子KLF4在真皮成纤维细胞中被miR-10/TFAP2A/TBX5轴抑制, objectType=article, longId=294403, objectId=ebfa29440350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebfa29440350, replyNumber=0, likeNumber=89, createdTime=2022-05-02, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebfa29440350, moduleTitle=ARD：抗纤维化因子KLF4在真皮成纤维细胞中被miR-10/TFAP2A/TBX5轴抑制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebfa29440350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930835, encodeId=20271930835f6, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Cell Death Differ：外泌体miRNA miR-101-3p和miR-423-5p可抑制髓母细胞瘤的发生发展, objectType=article, longId=214727, objectId=0e2e214e2713, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e2e214e2713, replyNumber=0, likeNumber=97, createdTime=2022-01-21, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e2e214e2713, moduleTitle=Cell Death Differ：外泌体miRNA miR-101-3p和miR-423-5p可抑制髓母细胞瘤的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e2e214e2713)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930836, encodeId=ce001930836f4, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Cell Death Dis：miR-526b-3p抑制肺癌的顺铂耐药和转移, objectType=article, longId=215572, objectId=d3e22155e24b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3e22155e24b, replyNumber=0, likeNumber=91, createdTime=2022-04-16, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3e22155e24b, moduleTitle=Cell Death Dis：miR-526b-3p抑制肺癌的顺铂耐药和转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3e22155e24b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930830, encodeId=6b7f1930830f8, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=JACC：miR-132，预防肥厚性心肌病心衰进展的有效靶点！, objectType=article, longId=212974, objectId=08ba2129e4fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08ba2129e4fc, replyNumber=0, likeNumber=108, createdTime=2021-09-29, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08ba2129e4fc, moduleTitle=JACC：miR-132，预防肥厚性心肌病心衰进展的有效靶点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08ba2129e4fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930831, encodeId=60e61930831c3, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=European Urology：循环miRs371a-3p已被证实为睾丸生殖细胞肿瘤的下一代血清生物标志物, objectType=article, longId=213186, objectId=885a2131860b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=885a2131860b, replyNumber=0, likeNumber=86, createdTime=2022-03-24, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=885a2131860b, moduleTitle=European Urology：循环miRs371a-3p已被证实为睾丸生殖细胞肿瘤的下一代血清生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=885a2131860b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930855, encodeId=83771930855cf, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Front Immunol：托珠单抗通过调控miR-146a-5p和EMMPRIN/CD147降低类风湿性关节炎血管生成, objectType=article, longId=293602, objectId=6e0b29360275, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e0b29360275, replyNumber=0, likeNumber=126, createdTime=2022-02-03, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e0b29360275, moduleTitle=Front Immunol：托珠单抗通过调控miR-146a-5p和EMMPRIN/CD147降低类风湿性关节炎血管生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e0b29360275)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930841, encodeId=e4ad193084120, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Front Neurol：电针治疗缺血性卒中小鼠潜在 mRNA 和 miRNA 调控网络的综合生物信息学分析, objectType=article, longId=218570, objectId=4b062185e03d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b062185e03d, replyNumber=0, likeNumber=87, createdTime=2021-12-23, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b062185e03d, moduleTitle=Front Neurol：电针治疗缺血性卒中小鼠潜在 mRNA 和 miRNA 调控网络的综合生物信息学分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b062185e03d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930825, encodeId=e625193082507, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Cell Death Differ：miR-30d抑制有氧糖酵解作用抑制胰腺癌的发生, objectType=article, longId=211729, objectId=2982211e2936, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2982211e2936, replyNumber=0, likeNumber=72, createdTime=2021-09-27, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2982211e2936, moduleTitle=Cell Death Differ：miR-30d抑制有氧糖酵解作用抑制胰腺癌的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2982211e2936)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930837, encodeId=4671193083e74, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=J Nanobiotechnology：上海长征医院杨立利课题组发现工程化的外泌体miR-181b通过调节巨噬细胞极化改善骨整合, objectType=article, longId=217335, objectId=d79721e335a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d79721e335a4, replyNumber=0, likeNumber=91, createdTime=2022-07-07, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d79721e335a4, moduleTitle=J Nanobiotechnology：上海长征医院杨立利课题组发现工程化的外泌体miR-181b通过调节巨噬细胞极化改善骨整合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d79721e335a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

miR

2020-05-29

smallant2002 (审核中...)

前往app查看评论内容

#miR#

ARD：独特的循环miRNA谱突出了Behçet综合征中的血栓炎症

2022-04-04

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Nat Commun：miRNA评分系统预测结直肠癌发病风险

2022-02-04

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Ann Oncol: MIRV对比研究者选择的化疗在铂耐药上皮性卵巢癌(EOC)患者中的疗效和安全性: III期研究FORWARD I的初次分析结果

2021-09-11

smallant2002 (审核中...)

前往app查看评论内容

#miR#

美国FDA批准 Cyltezo（阿达木单抗-adbm）作为第一个可与Humira互换的生物仿制药

2021-12-03

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Nat Commun：miRNA评分系统预测结直肠癌发病风险

2022-08-11

smallant2002 (审核中...)

前往app查看评论内容

#miR#

JEV:脂肪组织来源的干细胞细胞外囊泡通过骨保护素和miR-21-5p缓解骨质疏松症

2022-06-01

smallant2002 (审核中...)

前往app查看评论内容

#miR#

辉瑞和BioNTech的COVID-19疫苗Comirnaty对青少年具有高度保护作用

2022-06-14

smallant2002 (审核中...)

前往app查看评论内容

#miR#

复必泰（Comirnaty）加强针疫苗激发儿童对Omicron的免疫反应

2022-11-09

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Alvotech就美国专利和商业秘密纠纷与AbbVie达成和解，Alvotech的拟议Humira®高浓度生物仿制药(AVT02)可在美国销售

2022-07-30

smallant2002 (审核中...)

前往app查看评论内容

#miR#

撤稿！中国学者连续被撤稿129篇文章，基本都是动物和细胞实验层面，尤其是miRNA和lncRNA仍然是重灾区

2021-08-26

smallant2002 (审核中...)

前往app查看评论内容

#miR#

miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1

2022-10-11

smallant2002 (审核中...)

前往app查看评论内容

#miR#

ARD：抗纤维化因子KLF4在真皮成纤维细胞中被miR-10/TFAP2A/TBX5轴抑制

2022-05-02

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Cell Death Differ：外泌体miRNA miR-101-3p和miR-423-5p可抑制髓母细胞瘤的发生发展

2022-01-21

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Cell Death Dis：miR-526b-3p抑制肺癌的顺铂耐药和转移

2022-04-16

smallant2002 (审核中...)

前往app查看评论内容

#miR#

JACC：miR-132，预防肥厚性心肌病心衰进展的有效靶点！

2021-09-29

smallant2002 (审核中...)

前往app查看评论内容

#miR#

European Urology：循环miRs371a-3p已被证实为睾丸生殖细胞肿瘤的下一代血清生物标志物

2022-03-24

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Front Immunol：托珠单抗通过调控miR-146a-5p和EMMPRIN/CD147降低类风湿性关节炎血管生成

2022-02-03

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Front Neurol：电针治疗缺血性卒中小鼠潜在 mRNA 和 miRNA 调控网络的综合生物信息学分析

2021-12-23

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Cell Death Differ：miR-30d抑制有氧糖酵解作用抑制胰腺癌的发生

2021-09-27

smallant2002 (审核中...)

前往app查看评论内容

#miR#

J Nanobiotechnology：上海长征医院杨立利课题组发现工程化的外泌体miR-181b通过调节巨噬细胞极化改善骨整合

2022-07-07

科室
- - 订阅+
  - 更多科室
工具
服务